Zurueck zur Suche

Reporte zur Charge X006980

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

17Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 2 FL 2 IA 2 VA 1 OH 1 NJ 1 TX 1 PA 1 MO 1 NH 1 TN 1 WI 1

VAERS 2694634

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

schwer
Staat
VA
Alter
18,0
Geschlecht
M
Eingang
11.10.2023
Impfdatum
10.10.2023
Beginn
10.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Syncope

Symptomtext

18 year old male presented for vaccine follow-up. Pt did not have any records and proceeded with catch-up vaccination for school entry. Parent accompanied the pt. Prior to vaccine administration, Pt was feeling nervous but was comfortable to proceed. Pt had a vasovagal response after receiving all intramuscular and intradermal injections. Pt was diaphoretic, and was laid down. Initial BP taken of 84/60, Pt was responsive but eyes were closed. Pt opened eyes given an ice pack to neck and juice. Responded well. Pt was laid down for 10 minutes. After sitting, retake BP 110/75. Pt states that he was feeling better and wanted to continue with remaining subcutaneous injections. Pt left clinic stable. Pt was instructed if any other reactions occur to visit emergency care. Pt will follow up in 2 days at the clinic for TB test review and for a general nurse visit to ensure no further reactions occurred to vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2722882

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

moderat
Staat
OH
Alter
1,3
Geschlecht
F
Eingang
11.12.2023
Impfdatum
20.10.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Endotracheal intubation Injection site reaction Pneumonia Rash erythematous Rash vesicular Scab Skin lesion Varicella virus test positive Varicella zoster virus infection

Symptomtext

VZV (varicella zoster virus); pneumonia; This spontaneous report was received from other health care professional concerning a 15-month-old female patient. Her concurrent conditions included ARFGEF1 gene variant with developmental delay, decreased muscle tone and failure to thrive (FTT). The patient's medical history, drug reactions/allergies, and concomitant medications were not provided. It was reported that the patient had no recent VZV exposure, did not had chickenpox, nor prior history of herpes zoster or herpes zoster ophthalmicus. On 20-OCT-2023, the patient was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, 0.5 ml, administered as prophylaxis on the patient's left thigh, lot number X006980 with expiration date 07-MAR-2025 (route of administration was not reported). On an unspecified date in 2023, the patient developed varicella zoster virus accompanied with vesicular, erythematosus, and crusty rash (Varicella zoster virus infection), she had 4 lesions in total distributed in her scalp, left thigh, lower back, and lower neck. According to the reporter, the rash did not occur at the side of injection following the vaccination. The patient was hospitalized due to the event. Additionally, the patient had a possible pneumonia (Pneumonia) that was under investigation at the time of the report, the patient's hospitalization was prolonged for pneumonia treatment with emerging contribution of varicella zoster virus (VZV) in the setting of steroid therapy while intubated. On 24-NOV-2023, a sample was taken from the patient's scalp lesion to perform polymerase chain reaction (PCR). On 04-DEC-2023, the Company obtained the results of this test, which showed that the final specimen result was vaccine strain, the VZV DNA was amplified and showed vaccine-type. At the time of the report, the patient was in therapy with hydrocortisone, methylprednisolone, and prednisone. On an unknown date in 2023, the patient recovered from the events. Causal relationship between varicella virus vaccine live (Oka/Merck) (VARIVAX) and the events was not reported. Upon internal review, the event pneumonia was determined to be medically significant.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pneumonia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Developmental delay; Failure to thrive; Muscle tone decreased
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2676617

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

mild
Staat
NJ
Alter
51,0
Geschlecht
F
Eingang
25.08.2023
Impfdatum
23.08.2023
Beginn
23.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site induration Injection site swelling

Symptomtext

30X30mm Area of redness, swollen and hard around the site where injection was given. Started as a little lump she said then grew. She has not sought medical attention.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
none
Allergien
nkda
Vorherige Impfungen
-

VAERS 2674477

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

mild
Staat
TX
Alter
11,0
Geschlecht
M
Eingang
21.08.2023
Impfdatum
17.08.2023
Beginn
18.08.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Diarrhoea Influenza virus test negative Nausea SARS-CoV-2 test negative Vomiting

Symptomtext

Pt developed nausea, vomiting, and diarrhea that improved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
8/18/2023: COVID-19 and Flu were negative
Aktuelle Erkrankungen
none
Vorgeschichte
liver organ donor recipient due to biliary atresia, asthma, allergic rhinitis
Andere Medikamente
tacrolimus, cetirizine
Allergien
peanuts, tree nuts, and seafood
Vorherige Impfungen
-

VAERS 2670180

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

mild
Staat
FL
Alter
1,0
Geschlecht
M
Eingang
11.08.2023
Impfdatum
11.08.2023
Beginn
11.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Urticaria

Symptomtext

App. 15 minutes after immunizations were given, patient broke out in hives all over body. No respiratory symptoms or distress. No facial swelling or mouth swelling. Benadryl (Diphenhydramine 12.5mg/5ml) in the amount of 4 ml was given to the baby by mouth and the hives went away with 15-20 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Acute suppurative otitis media without spontaneous rupture of ear drum, bilateral
Vorgeschichte
None
Andere Medikamente
Derma-Smoothe Body Oil to skin
Allergien
None known
Vorherige Impfungen
-

VAERS 2725171

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge x006980

gering
Staat
FL
Alter
39,0
Geschlecht
F
Eingang
18.12.2023
Impfdatum
20.11.2023
Beginn
18.12.2023
Tage bis Beginn
28,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration

Symptomtext

Varivax was administered merely 5 days after MMR vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
SERTRALINE 25MG QD
Allergien
NONE
Vorherige Impfungen
-

VAERS 2708025

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
01.11.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered No adverse event

Symptomtext

Proquad and Varivax vaccines were given to same patient at same visit by accident. Proquad lot# X007085 Exp. 09/04/2024 Merck and Co. Inc NDC# 00006-417-00 Varivax Lot# X006980 Exp. 03/07/2025 Merck and Co., Inc. NCD 00006-487-00 Medication administered to or used by the patient Yes Outcome Pt is doing fine and did not have side effects. Reporter's recommendations All new and seasoned nurses will have another nurse verify the vaccines they are about to give by another nurse before administering. All nursing staff have been educated about making sure you are giving the correct vaccine and STOP and double check. Severity Error reached patient; no patient harm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2702144

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
NY
Alter
-
Geschlecht
F
Eingang
26.10.2023
Impfdatum
22.08.2023
Beginn
22.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy No adverse event

Symptomtext

No adverse event; HCP reported VARIVAX was administered to a pregnant patient. Reported patient denied pregnancy at time of immunization and declined pregnancy test. No additional AE/no PQC.; This spontaneous report was received from a nurse practitioner refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 22-AUG-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot #X006980, expiration date: 07-MAR-2025 (exact dose, route of administration and anatomical location were not reported) for prophylaxis. It was reported that the varicella virus vaccine live (oka/merck)(VARIVAX) was administered to a pregnant patient (exposure during pregnancy). The patient denied pregnancy at time of immunization and declined pregnancy test. No additional adverse event reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2698402

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
NY
Alter
16,0
Geschlecht
F
Eingang
19.10.2023
Impfdatum
22.08.2023
Beginn
22.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy Human chorionic gonadotropin positive No adverse event Ultrasound scan abnormal

Symptomtext

Patient came to PCP office on 08/22/2023 for vaccination only as scheduled. interpretation was provided. LMP was 07/12/2023. Patient reports hx of irregular menses. Denied pregnancy and declined urine HCG. HepB, HPV and varicella vaccines administered, patient left office without complaints. Patient went to see GYN on 09/28/2023 due to menses delay. Early pregnancy confirmed by urine HCG and bedside sono. Physical examination without abnormal findings. After initial visit with GYN, PCP and GYN were unable to reach out patient for f/u. feeling normal as usual. Denied any side effects from vaccination day. Nurse informed pt to continue to monitor for side effects, and encouraged patient to call clinic PRN. Pt voiced understanding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
Unknown
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2690717

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
MO
Alter
1,0
Geschlecht
M
Eingang
04.10.2023
Impfdatum
04.10.2023
Beginn
04.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

GAVE VARICELLA AND MMRV. SHOULD HAVE GIVEN VARICELLA AND MMR. NO ADVERSE EFFECTS NOTED AT TIME OF INJECTION.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
UNKNOWN
Allergien
NKA
Vorherige Impfungen
-

VAERS 2688026

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
NH
Alter
1,2
Geschlecht
M
Eingang
28.09.2023
Impfdatum
24.08.2023
Beginn
24.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

Child received the 2nd second dose of hepatitis A vaccine before the minimum interval. The 2nd dose of MMR and Varicella were administered before the 4th birthday.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Hemangioma right eyebrow
Andere Medikamente
Ferrous Sulfate 220 mg - oral solution Saline nasal 0.65% - spray aerosol
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2682640

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
IA
Alter
1,3
Geschlecht
U
Eingang
15.09.2023
Impfdatum
29.08.2023
Beginn
29.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose No adverse event

Symptomtext

No additional AEs or PQC reported; Caller reports PROQUAD and VARIVAX were inadvertently administered at the same office visit to a 16 month old; This spontaneous report was received from a registered nurse and refers to a 16-month-old patient of unknown gender. Information regarding the patient's medical history, concurrent conditions, historical drugs and concomitant therapies were not reported. On 29-AUG-2023, the patient was vaccinated inadvertently with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, 0.5 milliliter, lot #X011980 rHA, expiration date: 19-JUL-2024, administered intramuscularly for prophylaxis (strength was not provided); and with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #X006980, expiration date: 07-MAR-2025, administered intramuscularly for prophylaxis (strength was not provided) (accidental overdose.) No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2679681

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
TN
Alter
1,5
Geschlecht
M
Eingang
06.09.2023
Impfdatum
05.09.2023
Beginn
06.09.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Patient was receiving Catch Up doses on vaccine schedule. Patient was given Kinrix vaccine for (DTaP/IPV). Kinrix not licensed for <4yo.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
tylenol
Allergien
NKA
Vorherige Impfungen
-

VAERS 2679385

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
WI
Alter
2,0
Geschlecht
F
Eingang
05.09.2023
Impfdatum
10.08.2023
Beginn
10.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

Child received a proquad which contains varicella as well as a separate varicella vaccine same day. This resulted in a double dose of Varicells. Proquad was intended to be a MMR but was given as Proquad by mistake.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
no
Vorgeschichte
hypopigmentation
Andere Medikamente
motrin, tylenol as needed
Allergien
no known drug allergies
Vorherige Impfungen
-

VAERS 2679370

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
IA
Alter
1,2
Geschlecht
F
Eingang
05.09.2023
Impfdatum
05.09.2023
Beginn
05.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

The Hib vaccine was expired. I did not notice it until the patient had left. A new copy of their immunization record was sent to Mom and explained to Mom what had happened. They are moving so I wanted them to have a current, accurate record.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2677234

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
MD
Alter
5,0
Geschlecht
M
Eingang
28.08.2023
Impfdatum
24.08.2023
Beginn
28.08.2023
Tage bis Beginn
4,0
Dosis
1
Route/Site
- / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blister Papule

Symptomtext

small vesicle filled papules

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blister
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
no
Vorgeschichte
none
Andere Medikamente
children's multivitamins
Allergien
none
Vorherige Impfungen
-

VAERS 2675601

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006980

gering
Staat
NC
Alter
4,0
Geschlecht
F
Eingang
23.08.2023
Impfdatum
16.08.2023
Beginn
16.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

Dtap (dose number 5 in series) was ordered. Nurse administered Tdap instead. Provider made aware and mother made aware. No harm to child.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-